Monitoring the presence of 13 active compounds in surface water collected from rural areas in northwestern Spain by Iglesias Tilve, Alejandra et al.
Int. J. Environ. Res. Public Health 2014, 11, 5251-5272; doi:10.3390/ijerph110505251 
 
International Journal of 





Monitoring the Presence of 13 Active Compounds in Surface 
Water Collected from Rural Areas in Northwestern Spain 
Alejandra Iglesias 1, Carolina Nebot 1,*, Beatriz I. Vázquez 1, Claudia Coronel-Olivares 2,  
Carlos M. Franco Abuín 1 and Alberto Cepeda 1 
1 Department of Analytical Chemistry, Nutrition and Bromatology, Faculty of Veterinary Medicine, 
University of Santiago de Compostela, Lugo 27002, Spain; E-Mails: alejandra.iglesias@usc.es (A.I.);  
beatriz.vazquez@usc.es (B.I.V.); carlos.franco@usc.es (C.M.F.A.); alberto.cepeda@usc.es (A.C.) 
2 Instituto de Ciencias Básicas e Ingeniería, Área Académica de Química, Universidad Autónoma del 
Estado de Hidalgo, Carretera Pachuca-Tulancingo Km. 4.5, Ciudad del Conocimiento,  
Mineral de la Reforma, Hidalgo 42184, Mexico; E-Mail: ccoronel@uaeh.edu.mx 
* Author to whom correspondence should be addressed; E-Mail: carolina.nebot@usc.es;  
Tel.: +34-982-285-900; Fax: +34-982-254-592. 
Received: 10 February 2014; in revised form: 16 April 2014 / Accepted: 8 May 2014 /  
Published: 15 May 2014 
 
Abstract: Drug residues are considered environmental contaminants, and their occurrence 
has recently become a matter of concern. Analytical methods and monitoring systems  
are therefore required to control the continuous input of these drug residues into the 
environment. This article presents a suitable HPLC-ESI-MS/MS method for the 
simultaneous extraction, detection and quantification of residues of 13 drugs (antimicrobials, 
glucocorticosteroids, anti-inflammatories, anti-hypertensives, anti-cancer drugs and 
triphenylmethane dyes) in surface water. A monitoring study with 549 water samples was 
carried out in northwestern Spain to detect the presence of drug residues over two sampling 
periods during 2010, 2011 and 2012. Samples were collected from rural areas with and 
without farming activity and from urban areas. The 13 analytes were detected, and 18% of 
the samples collected showed positive results for the presence of at least one analyte. More 
collection sites were located in rural areas than in urban areas. However, more positive 
samples with higher concentrations and a larger number of analytes were detected in samples 
collected from sites located after the discharge of a WWTP. Results indicated that the 
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WWTPs seems to act as a concentration point. Positive samples were also detected at a site 
located near a drinking water treatment plant. 
Keywords: drugs; urban; rural; LC-MS/MS; environmental water; Spain 
 
1. Introduction 
Around the world, drugs consumption in both human and veterinary medicine has been increasing 
year after year. The consumption of pharmaceuticals in the EU is substantial, with approximately  
3,000 different active substances such as analgesics and anti-inflammatory drugs, contraceptives, 
antibiotics, beta-blockers, lipid regulators and neuroactive compounds being commonly used in human 
medicine [1]. These compounds enter the environment through many routes, including manufacturing, 
formulation, distribution, use and disposal. The use of pharmaceuticals by individuals is the main route. 
After ingestion, metabolites or drugs that are not completely metabolised in the body are expelled in 
faeces or urine and reach drains. Wastewater treatment plants (WWTPs) have no specific technologies 
to eliminate drugs entirely from the waste stream, so active compounds (drugs and metabolites) enter 
the aquatic environment straightforward from the effluents are discharged daily into rivers, making 
these residues pseudo-persistent pollutants. Pharmaceuticals widely used in the treatment of animals 
such as the antimicrobials, sulfonamides and quinolones can also be employed in the treatment of 
human infections. These drugs could be released directly to the environment through the extensive 
livestock-raising operations and can accumulate in manure pits or livestock waste that may be used to 
fertilise agricultural lands [2]. The result of these practices is that any residues of drug administered 
reach via runoff, rivers, lakes and seas and via filtration, groundwater, aquifers and wells. The direct 
contamination of aquatic environments by aquaculture can lead to the exposure of aquatic and 
sediment dwelling organisms to the contaminants [3]. The triphenylmethane dyes, malachite green (MG) 
and brilliant green (BG), originally used as dyeing agents in the textile and paper industries,  
are also observed as contaminants of the aquatic environment. The dyes were introduced illegally in 
1933 as ecto-parasiticides, fungicides and antiseptics in aquaculture because of their broad fungicidal 
and antiparasitical activity, and the dyes are effective against Gram-positive microorganisms [4].  
However, MG and BG are toxic to multiple organs in mammals and have negative effects on the 
immune and reproductive systems as well as genotoxic and carcinogenic properties [5,6], so their use 
in aquaculture is forbidden. 
The reason for the development of interest in the research is that reports on the occurrence of 
pharmaceuticals in the aquatic environment show that the pharmaceuticals are ubiquitous.  
The continued input of these compounds into the environment, even at low concentrations, potentially 
serves to sustain chronic exposure for aquatic organisms [7]. Toxic effects in non-target organisms 
have previously been reported by Jung et al., Kim et al., Li et al. and Madureira et al. [8–11]. 
Sulfonamides, propanolol, trimethoprim and diclofenac, inter alia, have been demonstrated to exert 
toxicity on plants, soil organisms, freshwater crustaceans, fish and zebrafish. 
Pharmaceutical pollutants are being discharged daily and continuously, albeit their detection in the 
aquatic environment can be complicated because these compounds are typically present at levels of ng·L−1 
Int. J. Environ. Res. Public Health 2014, 11 5253 
 
 
and pg·L−1 [7,12]. Detection of pharmaceuticals is influenced by the different properties of the 
multiple classes of drugs. Specific and suitable methods therefore need to be developed to identify and 
quantify the drugs in the aquatic environment. The analytical methods employed for the analysis of 
drugs are also varied, and the sample preparation procedure generally involves the use of large sample 
volumes, multiple extractions, sophisticated sample clean up, and/or derivatisation prior to analysis. 
Following extraction, depending on the nature of the target compound, pharmaceuticals are identified 
and quantified using a variety of analytical instruments. Analytical techniques including high performance 
liquid chromatography (HPLC) and gas chromatography (GC) allow the analysis of multiple analytes 
in the same extract when coupled to a mass spectrometer (MS), the combination of these techniques is 
commonly employed in environmental analyses [13–19]. However, detectors other than MS such as 
ultraviolet (UV), fluorescence (FL), chemiluminescence (CL) and other techniques such as capillary 
electrophoresis (CE) are also employed [20–25]. 
In the Mediterranean area of Spain, pharmaceuticals such as antimicrobials and anti-inflammatories 
and other compounds such as drugs of abuse have been reported several times in the 21st century [26–31]. 
The presence of pharmaceuticals has also been reported in Sevilla, Madrid and Galicia [32–34] surface 
waters. However, none of the publications cited, to the author’s knowledge, have previously investigated 
the presence of antimicrobials, anti-hypertensives, anti-cancer drugs, corticosteroids, anti-inflammatories 
and triphenylmethane dyes in river water samples, simultaneously. The geographical area investigated 
in this work contains the most important river in the Galician area, running through areas with high 
population density as well as areas dedicated to agriculture and livestock, thus indicating the 
importance of this community in the production of food from animal and vegetable origins.  
Because there are trout farms and paper industries in the sampling area, the possibility of finding 
residues of MG and BG in the aquatic environment must be considered. 
The aim of this work is to present a method using HPLC-MS/MS for the simultaneous identification 
and quantification of 13 target compounds (seven antimicrobials, one anti-hypertensive, one anti-
cancer drug, one synthetic corticosteroid, one non steroidal anti-inflammatory and two 
triphenylmethane dyes) in surface water. In particular, diclofenac, sulfamethoxazole, trimethoprim and 
oxolinic acid were included in the study because they are drugs commonly used in human medicine 
and their presence in environmental waters has been reported by different authors [14,17,32]. 
The assessment of the level of pollution generated in the production of food from animal origin 
derived from the use of the selected drugs has been carried out by analyzing water samples collected 
from rural areas with high and low density of farming activities. Urban areas located close to the 
discharge of WWTPs, were included in the study for comparison and based on the common presence 
of some of the drugs in these types of sampling points. Therefore, the method was validated in house 
and has been applied to the analysis of 549 surface water samples collected in rural and urban areas of 
the Galician environment during two different sampling periods. 
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2. Experimental Section  
2.1. Chemicals, Reagents and Stock Solutions 
Brilliant green, diclofenac, difloxacin, enrofloxacin, malachite green, marbofloxacin, oxolinic acid, 
propanolol, sarafloxacin, sulfamethoxazole, tamoxifen, triamcinolone and trimethoprim (all purity > 98%) 
and the internal standards (ISs) sulfadoxine-d3 and malachite green-d5 picrate were purchased from  
Sigma-Aldrich (St. Louis, MO, USA). All the therapeutic and chemical properties of the selected drugs are 
presented in Table 1. Methanol (HPLC-grade, ≥99.9%) was obtained from Scharlau Chemie  
(Barcelona, Spain), and formic acid (purity > 99% for analysis) was purchased from Acros Organics  
(Geel, Belgium). Hydrochloric acid solution (1 N HCl) was purchased from Merck (Darmstadt, Germany). 
Purified water was prepared in house with a Milli-Q water system from Millipore (Bedford, MA, USA), 
and nitrogen gas (purity > 99.98%) was generated by an in-house nitrogen generator from Peak 
Scientific Instruments Ltd. (Chicago, IL, USA). 
Table 1. Therapeutic class and chemical properties of the selected drugs. 
Analyte Therapeutic Class CAS Number Formula 
Brilliant Green Triphenylmethane dye 633-03-4 C27H34N2O4S 
Diclofenac Anti-inflammatory 15307-79-6 C14H11Cl2NO2 
Difloxacin Antimicrobial 98106-17-3 C21H19F2N3O3 
Enrofloxacin Antimicrobial 93106-60-6 C19H22FN3O3 
Malachite Green Triphenylmethane dye 2437-29-8 C23H25ClN2 
Marbofloxacin Antimicrobial 115550-35-1 C17H19FN4O4 
Oxolinic Acid Antimicrobial 14698-29-4 C13H11NO5 
Propanolol Anti-hypertensive 525-66-6 C16H21NO2 
Sarafloxacin Antimicrobial 98105-99-8 C20H17F2N3O3 
Sulfamethoxazole Antimicrobial 723-46-6 C10H11N303S 
Tamoxifen Anti-cancer 10540-29-1 C 26 H 29 NO 
Triamcinolone Glucocorticoid 124-94-7 C21H27FO6 
Trimethoprim Antimicrobial 738-70-5 C14H18N4O3 
The drugs were accurately weighed (±0.0001 g) on an analytical balance from Ohaus® GA200 
(Nänikon, Switzerland) to prepare stock solutions of individual compounds at a concentration of  
0.6 mg·mL−1 in methanol. These stock solutions were mixed with 0.1% of formic acid in methanol to 
obtain a stock solution of 1 µg·mL−1, and this solution was further diluted with 0.1% of formic acid in 
methanol to obtain standard mixtures of drugs at 12.5, 25, 50, 75, 100 and 150 ng·mL−1. The stock 
solutions of the ISs (sulfadoxine-d3 and malachite green-d5 picrate) at 0.6 mg·mL
−1 were mixed to 
obtain a working stock solution of 1 µg·mL−1 with 0.1% formic acid in methanol. All of the standard 
solutions were stored in the dark at −18 °C for a maximum of six months. 
2.2. Equipment 
Samples were analysed on an HPLC-MS/MS system consisting of an HPLC model 1200 G1312A 
from Agilent Technologies (Waldbronn, Germany) with a binary pump, a degasser and an autosampler. 
The MS was a model API 4000™ from Applied Biosystems MSD Sciex Instruments (Toronto, ON, 
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Canada) with an integrated TurboIonSpray® for molecule ionisation. The software Analyst 1.4.1,  
also from Applied Biosystems, MSD Sciex, was employed to acquire the data and control the system. 
The chromatographic analyses were performed by injecting 10 µL of the extract into a Synergi  
2.5 µm Polar-RP 100A column (50 × 2.0 mm) connected to a Polar-RP security-guard cartridge  
(4.0 × 2.0 mm), which were both obtained from Phenomenex (Macclesfield, UK). An MS2 Minishaker 
vortex mixer from IKA® (Staufen, Germany) and a vacuum station manifold with Strata®-X solid 
phase extraction (SPE) cartridges (60 mg, 3 mL), which were both obtained from Phenomenex 
(Macclesfield, UK), and a TurboVap® II evaporator from Zyrmark (Hopkinton, MA, USA) were 
employed for sample preparation and extraction. 
The physical and chemical parameters (nitrites, ammonium, conductivity, turbidity and pH) were 
measured for each collected sample. These analyses utilised the following equipment and kits: 
Visocolor® ECO nitrite test (0.02–0.5 mg·L−1 NO2
−) and ammonium 3 (0.2–3 mg·L−1 NH4+),  
both from Macherey-Nagel GmbH & Co. KG (Düren, Germany); a conductivity meter model 
CON6/TDS6 (Hand-held Conductivity/TDS Meter) from Eutech Instruments Pte. Ltd./Oakton 
Instruments (Illinois, IL, USA); a turbidimeter model TN-100 from Eutech Instruments Pte. Ltd. 
(Singapore, Singapore); and a pH meter model MicropH 2000 from Crison (Barcelona, Spain). 
2.3. HPLC-MS/MS Conditions 
Separation of analytes was achieved using a gradient mixture of two components, A (0.1% formic 
acid in water) and B (0.1% formic acid in methanol). The gradient programme employed is shown in 
Table 2, and the flow rate was 0.2 mL·min−1 during the whole run. 
Table 2. Gradient program of the HPLC-MS/MS method developed. 
Total Time (min) Mobile Phase A (%) Mobile Phase B (%) 
0 90 10 
2 90 10 
7 50 50 
15 25 75 
24 0 100 
28 0 100 
33 75 25 
36 90 10 
40 90 10 
Notes: A: 0.1% formic acid in water; B: 0.1% formic acid in methanol. 
Mass spectrometric measurements were performed using positive electrospray ionisation (ESI+), 
and drug identification was performed using two multiple reaction monitoring (MRM) transitions and 
their retention times (tR). Standard solutions of the individual drugs in a concentration of 1 µg·mL
−1 in 
0.1% formic acid in methanol were infused directly into the mass spectrometer, using a 1 mL syringe 
pump (model Gastight® 1001), which was purchased from Hamilton (Bonaduz, Switzerland), at a flow 
rate of 5 µL·min−1. The optimum cone voltage and collision gas energy were selected when they gave 
the most intense signals. Then, the HPLC with a Synergy-Polar column was connected to the MS. 
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To monitor a specific transition between a precursor and a product ion, the following MS parameters 
needed to be set: declustering potential (DP), entrance potential (EP), collision energy (CE) and cell 
exit potential (CXP). These parameters varied for each compound and changed automatically during 
the run, as summarised in Table 3. The following MS parameters were kept constant during the run:  
a source temperature of 650 °C, a vacuum gauge of 4.1·10−5 Torr, an ion spray voltage of 5,000 V and 
a curtain gas pressure of 12 psi. The first ion source was set at 45 psi, and the second ion source was 
set at 50 psi. For all monitored transitions, the dwell time was 10 ms. 
Table 3. Retention time (tR), precursor and product ions and MS parameters employed to 
identify the selected drugs. 







Precursor > Product Ion 1 
DP EP CE CXP
Brilliant Green 34.09 385 341 241 61 10 53 10 
Diclofenac 20.29 296 214 250 51 10 43 14 
Difloxacin 15.44 400 299 356 71 10 27 32 
Enrofloxacin 14.91 360 316 342 76 10 28 8 
Malachite Green 25.12 329 208 165 111 10 43 18 
Marbofloxacin 13.74 363 72 320 76 10 51 4 
Oxolinic Acid 16.62 262 216 160 36 10 39 14 
Propanolol 15.97 260 116 183 106 10 23 10 
Sarafloxacin 16.05 386 342 299 76 10 23 22 
Sulfamethoxazole 13.20 254 156 92 81 10 25 14 
Tamoxifen 21.2 372 340 235 106 10 73 14 
Triamcinolone 15.34 395 375 357 66 10 15 6 
Trimethoprim 12.05 291 230 123 56 10 35 20 
Sulfadoxine d3 13.70 314 156 108 41 10 27 12 
Malachite green d5 picrate 25.8 334 213 170 126 10 47 24 
Notes: DP: Declustering potential; EP: Entrance potential; CE: collision energy; CXP: cell exit potential. 
2.4. Study Site Description 
The geographical area investigated is located in the extreme northwest (NW) portion of the  
Iberian Peninsula, just north of Portugal. The Miño River is an international river with a length of 
approximately 340 km. The source of the Miño River lies in Pedregal of Irimia, which is 50 km north 
of Lugo in Galicia, Spain (Serra de Meira, Lugo, at 750 m elevation) and in the last 75 km, the river 
defines the border between Portugal and Spain. The Miño River is the most important drainage basin 
in NW Spain, extending over 17,757 km2 with abundant areas dedicated to agriculture and livestock 
distributed along its path to the Atlantic Ocean [35]. The landscape of Galicia is dominated by the 
valleys created by the Miño River and its tributaries. Samples were collected from the Miño River and 
one of its main tributaries, the Asma River. The study area encompassed the upper basin, which 
includes the metropolitan area of Lugo, with approximately 98,000 residents (INE 2011) and areas 
dedicated to agriculture and farm production. 
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2.5. Sampling Strategy, Method and Conservation 
Our sampling strategy was designed based on previous work where veterinary drugs were 
investigated in river water from different areas with and without farming activity using a total of  
14 sampling points. Six of the points were located in rural areas and the other eight were chosen at 
different points along the Miño River, Galicia’s largest river, which goes across both rural and urban 
areas (Figure 1). 
Figure 1. Locations of the sampling sites selected for the monitoring study. 
 
The method was developed and validated with river water samples collected from the Miño River, 
and the monitoring study was conducted with Galician fresh water. A total of 267 river samples of 1-L 
were collected in 1-L polyethylene plastic vessels during two different sampling periods, the first 
sampling period over a nine-week period from October to December 2010 and the second sampling 
period over a seven-month period between November 2011 and May 2012. The sampling sites were 
distributed along the Miño River between the villages of Rábade and Chantada in the province of Lugo. 
Of a total of 14 points, eight were located at the Miño River, one in its tributary the Asma River and 
five in streams and brooks (Figure 1). 
All the samples for method validation and monitoring studies were filtered upon arrival at the 
laboratory and divided into replicate samples of 500 mL and were stored at 4 °C until analysis was 
carried out, which was always performed the day after sampling. The extracts were stored at −18 °C 
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until their HPLC-MS/MS analysis was performed which took place within no more than seven days 
after the extraction. To quantify the analytes correctly all the river water samples were spiked with  
50 µL of the IS solution and a blank and two control samples (Milli-Q water and Milli-Q water 
samples spiked at 75 and 150 ng/L, respectively) were filtered, stored and processed in the same way 
as our natural water samples for identification of contamination risk during sample processing. 
2.6. Analytical Procedure 
Analytical determinations were carried out using a modification of a previously reported method [36] 
based on solid-phase extraction (SPE) and determination by high performance liquid chromatography 
coupled to tandem mass spectrometry. Filtered samples were acidified with 1 N HCl solution to a  
pH of 3 and loaded in to a SPE cartridge (Strata®-X, Phenomenex, Torrance, CA, USA) activated with 
4 mL of methanol and 4 mL of water at pH 3. The analytes were eluted with 8 mL of methanol and 
evaporated to dryness under a nitrogen stream at 45 °C. The extracts were reconstituted with 200 µL of 
0.1% formic acid in methanol and stored at −18 °C until further analysis by HPLC-MS/MS. The 
extracts were analysed within one week following extraction. 
The samples employed for the determination of physical and chemical parameters  
(nitrites, ammonium, conductivity, turbidity and pH) were stored at 4 °C in the laboratory until 
analysis, which was carried out within one day of sampling. The physical and chemical parameters 
were determined following the manufacturers’ instructions for the respective kits and equipment. 
2.7. Validation Procedure 
As the method employed is a modification of a previously reported method, validation had to  
be performed. 
The linear response of the instrument to standard solutions containing all the selected drugs at  
six different concentrations (1, 5, 10, 50, 100 and 200 ng·mL−1) was investigated. These standard 
solutions were employed to obtain the instrument calibration curves (ICCs). The instrument detection 
limit (IDL) was defined as the concentration that gave a signal-to-noise (S/N) ratio above 3, and the 
instrument quantification limit (IQL) was defined as the concentration that gave an S/N above 10.  
The linearity of the whole method, extraction and HPLC-MS/MS detection, was evaluated using 
matrix-matched samples with river water samples spiked with all the selected drugs at the following 
concentrations: 1, 5, 10, 20, 50, 75, 100, 150 and 200 ng·L−1. These samples were employed to build 
sample calibration curves (SCCs) and to determine the limit of detection (LOD) for the method,  
which is defined as the lowest concentration that gave an S/N above 3 and a method limit of 
quantification (LOQ) at an S/N above 10. Once the LOD was established, the method detection limit 
(MDL) was also calculated following the Environmental Protection Agency (EPA) procedure from  
CFR 136, Appendix B criteria [37]. The MDL is defined as the minimum concentration of a substance that 
can be measured and reported with a 99% confidence that the analyte concentration is greater than zero. 
The MDL is determined from the replicate analysis of a sample in a given matrix containing the analyte. 
The analytical method was validated in terms of selectivity, linearity, LOD, LOQ, MDL repeatability, 
precision and accuracy. 
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2.8. Statistical Analysis 
Once the results from the identification and quantification of the selected analytes and the results 
from the determination of the physicochemical parameters were obtained from the monitoring study, 
they were analysed using the software PASW Statistics 18 (SPSS Inc., Chicago, IL, USA) to identify 
statistically significant trends in the drug concentrations. The effects of the weather conditions, 
sampling site characteristics (rural and urban areas), sampling date and physical and chemical 
parameters (nitrites, ammonium, conductivity, turbidity and pH) of the water samples collected were 
tested using one-way ANOVA (p < 0.05). 
3. Results and Discussion 
3.1. Optimisation of the HPLC-MS/MS and Extraction Protocols 
Initially, the method employed by Nebot et al. [36] was selected for the analysis of the collected 
samples. However, based on the capability of a Synergy-Polar column in the laboratory, this column 
was selected to perform the analysis instead of a Luna column. This change of the chromatographic 
columns could explain the results obtained for the paracetamol peak, which did not have a Gaussian 
shape. The results of the analysis of this compound consequently had to be discarded. More compounds 
were also included in the method (brilliant green, cefalexin, difloxacin, enrofloxacin, gentian violet, 
leucomalachite green, malachite green, marbofloxacin, norfloxacin, oxolinic acid, sarafloxacin and 
triamcinolone). The mobile phase employed was different: methanol and water acidified with formic 
acid instead of ammonium acetate was employed because the best peak resolution and peak shape were 
achieved with a combination of these solvents. Formic acid aided in the prevention of peak tailing and 
provided sufficient ionisation [38,39]. The reproducibility of the tR of the selected drugs was evaluated 
through the RSDs, and their values were in the range between 0.44% and 5.40%. 
The SPE protocol described by Nebot et al. [36] was initially employed but for the final method 
some modification were applied. The cartridges were conditioned with 1 mL less of methanol and 
water, the sample flow was the same but the elution of the drugs was conducted differently.  
Methanol alone was employed instead of acetone and methanol because a larger number of analytes 
were recovered. Instead of 2 L of sample, a volume of 500 mL was employed to spend as little time as 
possible during extraction and to avoid product degradation due to the laboratory conditions.  
The acidification of the water samples to pH 3 with 1 N HCl solution was performed to improve the 
interaction between the elution solvent and the analytes in the SPE [40]. From 19 pharmaceuticals 
(brilliant green, cefalexin, diclofenac, difloxacin, enrofloxacin, erythromycin, gentian violet, 
leucomalachite green, malachite green, marbofloxacin, mefenamic acid, norfloxacin, oxolinic acid, 
propanolol, sarafloxacin, sulfamethoxazole, tamoxifen, triamcinolone and trimethoprim), a total of  
13 analytes were extracted satisfactorily. Recoveries of cefalexin, erythromycin, gentian violet, 
leucomalachite green, mefenamic acid and norfloxacin could not be taken into account because of their 
low recoveries. Some steps during the extraction of the fortified samples led to degradation and low 
recoveries of the analytes. In particular, the pH adjustment inhibited the extraction of erythromycin 
and mefenamic acid. Recoveries of trimethoprim, sulfamethoxazole, propanolol, diclofenac and 
tamoxifen from fortified river water were higher in this study compared to Nebot et al. [36] most likely 
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due to a different extraction protocol, but the LOD and LOQ were lower certainly due to lower sample 
volume. Another factor that could have improved recoveries would be the use of an internal standard, 
contrasting with the procedure of Nebot et al. [36], who quantified 12 human drugs without the 
employment of any IS. In this research, the IS sulfadoxine-d3 was employed to quantify the selected 
drugs in accordance with Hao et al., Hilton et al. and Kasprzyk-Hordern et al. [41–43], who employed 
one or two ISs to quantify 13 drugs from different therapeutic classes in water samples. 
A test was conducted to determine the percent of compound lost during the extraction protocol,  
in which a battery of water samples was fortified at a concentration of 25 ng·L−1 after the evaporation 
step. The results showed a loss between 40%–50% of diclofenac, MG, oxolinic acid, propanolol, 
sulfamethoxazole and tamoxifen during the extraction step. 
3.2. Method Validation 
The selectivity of the method was investigated by comparing the two MRM transitions of the 
selected analytes obtained from a standard solution, non-fortified river samples and fortified river 
samples. The method selectivity was demonstrated by noting the absence of interference peaks at the  
tR of the analytes and IS for both selected transitions. 
When a standard solution containing a mixture of the analytes was injected at different concentrations, 
the IDL obtained ranged from 0.2 to 6.4 ng·mL−1, and the IQL ranged from 0.3 to 6.7 ng·mL−1 (Table 4). 
A linear response was also observed for concentrations between 1–200 ng·mL−1, with a mean R2 
higher than 0.991. The linearity of the whole procedure, samples spiked and extracted as described 
previously, was observed to have a mean R2 above 0.979 for a concentration range between 1 and  
200 ng·L−1 (Table 5). 
For fortified samples, the LOD was in the range of 1–3.43 ng·L−1, and the LOQ was in the range of 
3.0–5.15 ng·L−1 (Table 4). Although there are reports of lower LODs and LOQs, for example, for 
tamoxifen (0.03 and 0.08 g·L−1) [36], triamcinolone (0.5 and 1.67 ng·L−1) [44], and marbofloxacin 
(LOD = 0.8 ng·L−1) [40], other studies present LOD and LOQ values for enrofloxacin (LOD = 34 ng·L−1, 
LOQ = 120 ng·L−1) and trimethoprim (LOD = 91 ng·L−1, LOQ = 310 ng·L−1) higher than those reported 
in this work [45] where ion trap MS was used by Dinh et al. [14] for enrofloxacin (LOD = 3.3 ng·L−1, 
LOQ = 11 ng·L−1) and oxolinic acid (LOD = 1.7 ng·L−1, LOQ = 5.7 ng·L−1) and sarafloxacin  
(LOD = 1.1 ng·L−1, LOQ = 3.6 ng·L−1). Martín et al. and Batt et al. reported LOD and LOQ values for 
propanolol (LOD = 1 ng·L−1, LOQ = 2 ng·L−1 and LOD = 0.6 ng·L−1, LOQ = 2.1 ng·L−1) [32,46], 
lower than the present work. However, for the compounds diclofenac, sulfamethoxazole and 
trimethoprim (LOD = 15 ng·L−1, LOQ = 49 ng·L−1, LOD = 8 ng·L−1, LOQ = 28 ng·L−1, LOD = 6 ng·L−1, 
LOQ = 20 ng·L−1), the values were considerably greater [32]. Data from Ashton et al. [47] showed 
much higher values than those obtained in this work for sulfamethoxazole, trimethoprim, propanolol, 
diclofenac and tamoxifen. To the authors’ knowledge, no LOD and LOQ values are available for 
malachite green and brilliant green in surface water to compare with those obtained in this study. 
The MDL was calculated for each analyte using river samples fortified with the pharmaceuticals at 
a concentration of 25 ng·L−1. MDL values for each analyte are summarised in Table 4, and the range 
was between 2 and 15.1 ng·L−1. The MDL values for diclofenac and sulfamethoxazol achieved during 
this research were lower than those published by Cahill et al. and Yang et al. [48,49]; Muñóz et al. 
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reported the same MDL for propanolol (2 ng·L−1) [50]. However, data obtained for trimethoprim and 
enrofloxacin were higher than those reported by Senta et al., who achieved MDLs for these 
compounds between 1–8.5 ng·L−1 [39]. Batt et al. also report MDLs for sulfamethoxazole and 
propanolol (5.5 and 1.3 ng·L−1) [46], and Kasprzyk-Hordern et al. report an MDL for diclofenac  
(0.05 ng·L−1) [51]. Once again, no data for malachite green and brilliant green in surface water 
samples were found. 
Table 4. Instrument detection limit (IDL), instrument quantification limit (IQL), limit of 
detection (LOD), limit of quantification (LOQ) and method detection limit (MDL). 
Analyte IDL (ng·mL−1) IQL (ng·mL−1) LOD (ng·L−1) LOQ (ng·L−1) MDL (ng·L−1)
Brilliant Green 0.2 0.3 2.6 3.0 7.4 
Diclofenac 0.7 0.8 2.0 2.10 11.1 
Difloxacin 0.3 0.5 1.0 3.0 8.8 
Enrofloxacin 5.4 5.8 1.37 5.15 8.1 
Malachite Green 0.2 0.3 1.5 3.3 10.9 
Marbofloxacin 0.2 0.3 1.0 3.0 8.1 
Oxolinic Acid 6.4 6.7 3.43 3.86 9.3 
Propanolol 0.2 0.3 1.0 3.0 2.0 
Sarafloxacin 4.6 4.8 2.1 5.2 11.9 
Sulfamethoxazole 0.2 0.3 1.0 3.0 11.2 
Tamoxifen 0.2 0.3 2.0 3.0 13.5 
Triamcinolone 0.9 1.1 1.0 3.0 7.6 
Trimethoprim 0.2 0.3 1.0 3.0 15.1 
Table 5. Regression coefficients (R2), mean recoveries and relative standard deviation 
(RSD) of the selected veterinary drugs. 
Analyte ICC R2 SCC R2 Mean Recovery (%) RSD (%) 
Brilliant Green 0.996 0.989 80 20 
Diclofenac 0.999 0.999 77 16 
Difloxacin 0.993 0.995 60 26 
Enrofloxacin 0.997 0.979 60 27 
Malachite Green 0.999 0.997 79 25 
Marbofloxacin 0.991 0.986 60 23 
Oxolinic Acid 0.994 0.991 62 25 
Propanolol 0.999 0.999 93 10 
Sarafloxacin 0.995 0.990 72 20 
Sulfamethoxazole 0.999 0.999 82 25 
Tamoxifen 0.994 0.999 75 20 
Triamcinolone 0.994 0.993 68 22 
Trimethoprim 0.999 0.998 80 21 
Notes: ICC: Instrument calibration curve; SCC: Sample calibration curve. 
Mean recoveries of the selected drugs are summarised in Table 5, where recoveries higher  
than 60% can be observed. The highest recoveries were obtained for brilliant green, propanolol, 
sulfamethoxazole and trimethoprim with values above 80% and RSDs lower than 25%.  
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Diclofenac, malachite green, sarafloxacin and tamoxifen showed recoveries between 72% and 79%, 
and the RSDs were not higher than 25%. The lower recoveries (60%–68%) corresponded to the 
quinolone drugs (difloxacin, enrofloxacin, marbofloxacin and oxolinic acid) and triamcinolone with 
the RSD between 22% and 27%. 
Dinh et al. reported results for recoveries of trimethoprim and sulfamethoxazole (90% and 94%) 
when the spiked level was 200 ng·L−1 [14]. Recoveries for enrofloxacin (83%) and oxolinic acid (75%) 
were higher and for sarafloxacin were similar (79%). Tamtam et al. obtained, in general,  
lower recoveries with a spiked level of 100 ng·L−1 in river water samples using UPLC-MS/MS for 
trimethoprim, sulfamethoxazole, sarafloxacin and difloxacin (80%, 68%, 44% and 55%) with high 
RSDs (11%–29%) [17]. Recoveries for enrofloxacin were approximately 60% as in the present study. 
Other publications reported a range of mean recoveries between 38% to 88% for the selected drugs 
investigated in this study [39,47,52], lower than the values obtained in this research. 
3.3. Monitoring the Presence of Drugs in Spanish Rivers 
Of 549 water samples collected during the two sampling periods, 100 samples (18%) were positive 
for the presence of one or more of the selected drugs. The 13 analytes investigated were detected in at 
least one sample. The mean percentage of positive samples according to the type of area was 17% in 
urban areas, 4% in rural areas with farming activity and 2% in rural areas without farming activity. 
Overall, the percentage of positive samples obtained for each sampling period was similar: 19% and  
17% for the first and the second, even if the number of samples collected was different,  
235 (first sampling period) and 314 (second sampling period). When results for each sampling area 
were compared by sampling period, results were similar, particularly for those samples collected from 
urban areas. Sampling points located in these areas gave a higher percentage of positive samples:  
16% during the first sampling period and 18% during the second sampling period. However, we noticed 
that even if the total percentage of positive samples detected in rural areas did not exceed 6%,  
during the first sampling period the percent of positive samples was double the percentage of positive 
samples in the second sampling period. Of all the sampling points located in urban areas, those situated 
after the discharge point of a WWTP (sites 3 and 13) gave the higher number of positive samples,  
with a range of detections between 24% and 33% of the positive samples and with a percent of 
detection at each site of 60% and 80% for sites 3 and 13. These results for the area selected from the 
Galician environment correlated with the results reported by many other authors who detected the 
presence of pharmaceuticals in surface water samples collected after the discharge of a  
WWTP [14,43,53]. Sites classified as rural areas with low farming activity were the sites with the 
lowest number of detections but with the highest variation between the different sampling periods. 
These results support the idea that contamination of the samples analysed comes from human activity. 
It should be highlighted that the number of analytes detected was different in each sampling period. 
In the second sampling period, all the analytes selected for the study were detected in at least  
one sample. In the first sampling period, only four drugs were measured (diclofenac, marbofloxacin, 
sulfamethoxazole and trimethoprim). These results could certainly be due to a longer sampling time,  
as the second period was conducted over seven months while the first was conducted over only three 
months. Consequently, during the second sampling period, 60 more samples were collected.  
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The fact that the second sampling period took longer may have highlighted the influence of livestock 
in terms of health, feeding or environmental conditions. Weather conditions were also different during 
the two sampling periods. Mean solar radiation was 70% higher during the second sampling period, 
and mean precipitation was 73% higher during the first sampling period. 
Analytes detected and their concentrations are summarised in Table 6 and chromatograms of a 
surface water sample are represented in Figure 2. If the results are assessed by the type of drugs and 
their frequency of detection, diclofenac was the drug with more detections in both sampling periods, 
with 29 (in the first) and 40 (in the second), followed by sulfamethoxazole with nine (in the first) and  
33 (in the second) and by trimethoprim with seven (in the first) and 39 (in the second) also the number 
of detections of sulfamethoxazole and trimethoprim was in the same range for each sampling period, 
possibly because these drugs are usually administered together in both veterinary and human medicine 
as they have a synergistic effect. Their high frequency of detection could be due to their frequent use 
because of their low cost and their broad spectrum of activity to treat bacterial infections [54,55]. 
Sulfonamides such as sulfamethoxazole and trimethoprim have been detected in surface waters 
worldwide [56–59]. These results correlated with data reported by Huang et al. who suggested that 
sulfonamides are the most common water pollutants among various antibiotics based on information 
concerning their environmental fate and predicted concentrations [60]. Huang et al. predicted that,  
for example, sulfamethoxazole was most likely to be present in municipal effluent and sulfamethazine 
in agricultural runoff [60]. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID), commonly 
used to treat inflammatory rheumatic diseases in humans, so its detection at sites located after the 
discharge of a WWTP is quite expected and, in fact, this drug was detected in 76% of the samples (n = 
21). When the data were treated statistically, significant differences (p < 0.05) were found only for 
sulfamethoxazole and diclofenac according to sampling period. These two analytes were more 
frequently detected during the second sampling period when their detection was double. When a 
similar analysis was conducted by sampling month, no significant differences were observed for 
diclofenac or sulfamethoxazole, but significant differences were observed for trimethoprim. 
Concentration and frequency of detection of these analytes also showed significant differences  
(p < 0.05) when they were analysed according to sampling points. Site 13 was the site with the highest 
number of detections: 29 for diclofenac, 24 for trimethoprim, 19 for sulfamethoxazole and 10 for 
propanolol. 
The concentrations of the drugs measured in this research were between 2.8 to 171.4 ng·L−1 (Table 6). 
Based on the therapeutic class of the drugs, antimicrobial is the group most frequently detected, with 
104 detections and a mean concentration of 53.4 ng·L−1. The second group most frequently detected 
was the anti-inflammatory agent diclofenac, with 69 detections and a mean concentration of  
13.6 ng·L−1, followed by the anti-hypertensive propanolol. The highest concentration of drugs 
measured during this study corresponded to sarafloxacin but this compound was detected only once,  
in the sampling site located downstream from the discharge of one WWTP. The detection of 
sarafloxacin could be due to the entrance of some animal residue into the WWTP because this 
fluoroquinolone is specially employed in poultry to prevent and treat infections. The drug measured at 
the second highest concentration (164.5 ng·L−1) was also a fluoroquinolone, enrofloxacin. This sample 
was collected at one of the sites located in a rural area with farming activity (point 7). This site is 
surrounded by greenery where cow droppings were found on the bank of the river, most likely due to 
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the easy access for grazing livestock to drink water. Like sarafloxacin, the frequency of detection of 
enrofloxacin was low: enrofloxacin was measured in only three samples collected from three different 
sites (1, 7 and 13), each site classified differently. Trimethoprim was the analyte measured at the third 
highest concentration (110.4 ng·L−1). As mentioned earlier, this drug was frequently detected with a 
mean concentration of 13.8 ng·L−1 in both sampling periods. The highest observed concentration of 
diclofenac, the compound most frequently detected, was 45.9 ng·L−1, and its mean concentration was 
16.6 ng·L−1 in both sampling periods. Jiang et al. published values of concentrations in the same range 
for sulfamethoxazole (4.86–53.24 ng·L−1) and trimethoprim (2.23–62.39 ng·L−1) in China [61]. 
Diclofenac was detected in the range of 2.8–46 ng·L−1 in 69% of the positive samples during this 
research. A similar frequency of detection was reported by Kasprzyk-Hordern et al. who detected 
diclofenac in rivers of the UK in the range of 1–261 ng·L−1 at a mean percentage frequency of 74% [51]. 
The greater concentration of trimethoprim (110.4 ng·L−1) was detected in a sample collected from a 
rural site surrounded by bovine livestock farms, specifically dairy cattle. Dinh et al. also reported 
concentrations for sulfamethoxazole (3.6–1,435 ng·L−1) and trimethoprim (8–254 ng·L−1) downstream 
of WWTPs [14]. However, if data obtained during this research are compared with concentrations of 
residues found in surface waters in Spain (up to 20 ng·L−1), the United Kingdom (up to 42 ng·L−1), 
South Korea (3.2–5.3 ng·L−1) and in Serbia (25 ng·L−1) [47,62–64], the concentration of the analytes 
measured in the Galician environment were higher. 
Table 6. Maximum, minimum and mean concentrations of the selected drugs detected in 










Brilliant Green 7.9 3.3 5.6 2 
Diclofenac 46.0 2.8 13.6 69 
Difloxacin 8.5 8.5 8.5 1 
Enrofloxacin 164.5 60.0 119.9 3 
Malachite Green 9.0 9.0 9.0 1 
Marbofloxacin 20.1 3.6 8.8 10 
Oxolinic Acid 39.1 39.1 39.1 1 
Propanolol 62.6 4.2 11.5 14 
Sarafloxacin 171.4 171.4 171.4 1 
Sulfamethoxazole 40.1 3.0 10.7 42 
Tamoxifen 11.7 3.5 7.5 6 
Triamcinolone 8.4 8.4 8.4 1 
Trimethoprim 110.4 3.5 16.1 46 
 
Another active compound frequently detected during this research was propanolol, which is a beta 
blocker drug involved mainly in relaxing blood vessels and decreasing heart rate to improve blood 
flow and lower blood pressure. Propanolol was detected in 14 samples in the range of 4.2–62.6 ng·L−1, 
similar to the values reported by Kasprzyk-Hordern et al. (3–91 ng·L−1) in the rivers of the UK [51] 
and higher than the values measured by Alder et al. in Switzerland (7–8 ng·L−1) [13]. The highest 
concentration of propanolol found during this work (37.4 ng·L−1) was measured in a sample collected 
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at a site described as a rural area. Most of the detections of this compound occurred at the sites located 
after the discharge of the WWTPs, most likely due to low removal during treatment at the WWTP as 
reported by Gros et al. who observed a rate of removal for this compound below 20% [65].  
These results are in accordance with data published by Martín et al., who detected propanolol in 100% 
of the samples collected downstream of discharge from four WWTPs [32]. The range of concentrations 
reported for this compound was between 30 to 720 ng·L−1, ten times higher than the concentrations 
measured in the River Miño. However, the area investigated was more or less than ten times less 
populated than the Guadalquivir area studied by Martín et al. [32]. As these drugs are not allowed in 
food-producing animals, the presence of propanolol in a sample collected from a rural area could be 
due to its application to animals not dedicated to food production, or the presence of this compound 
could also be due to a leak from the septic tanks. 
Figure 2. MRM chromatograms for sulfamethoxazole (37.7 ng·L−1),  
trimethoprim (64.3 ng·L−1) and diclofenac (31.4 ng·L−1) detected in galician surface water. 
 
 
The antimicrobial marbofloxacin was detected with a range in concentration from 3.6 to 20.1 ng·L−1, 
where the highest value was found at a rural site (point 1) located in the Miño River flow.  
The second greatest concentration was detected at a site also located in the Miño River but on its way 
through the city of Lugo (point 12). The rest of the analytes selected in this study were detected at a 
percentage less than 10%. Like sarafloxacin, oxolinic acid was detected only once (39.1 ng·L−1) in a 
sample collected at a site located near the discharge of a WWTP (point 13). Oxolinic acid had also 
been found in the Seine River at a similar concentration (23 ng·L−1) by Dinh et al. [14]. 
The presence of the triphenylmethane dyes, brilliant green and malachite green, in the Galician 
water is a matter for further study, even if brilliant green was detected only twice and malachite green  
once in concentrations that do not exceed 9.0 ng·L−1. As previously mentioned, these compounds are  
multi-organ toxics to mammals that show serious negative effects [5]. The detections of these  
two compounds were at the same sampling site, with two of them observed on the same day.  
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The compounds were found at a site located near the discharge of the WWTP located at site number 13, 
flowing downstream of the city of Lugo. The hypothesis is that these residues could originate from a 
paper industry located on the upper side of the city and perhaps be swept away by the Miño River to be 
found in such low concentrations on the lower side or maybe due to the fish farms that are located  
near the city of Lugo, but this is only a hypothesis because the use of these drugs is forbidden for 
processing of all categories of edible fish, including fish eggs. 
For each collected sample, physicochemical parameters such as nitrites, ammonium, conductivity, 
turbidity and pH were measured. Statistical analysis (ANOVA and a linearity test) was conducted for 
the concentration of the analytes and these parameters. However, no significant differences (p < 0.05) 
were found for ammonium, nitrites, conductivity, turbidity and pH. When statistical analysis  
was conducted with weather conditions (mean temperature (°C), mean precipitation (mm),  
mean humidity (%) and mean solar radiation (10 kJ/m2)), significant differences (p < 0.05) were 
observed for diclofenac and mean temperature. Samples that contained a measurable concentration of 
diclofenac were collected on days when the temperature was equal to or above 15 °C. Diclofenac was 
more frequently detected in samples collected in urban areas, especially after the discharge of a 
WWTP, but in the samples collected from rural areas, diclofenac was detected on days when the mean 
temperature was above 17 °C, most likely because treated animals were put out to pasture.  
Significant differences (p < 0.05) were also observed for propanolol concentration and precipitation. 
This analyte was generally detected on days when rainfall was not registered. The lack of detection on 
rainy days could have being due to a dilution effect, as most samples contained a concentration of 
propanolol below 10 ng·L−1. No significant differences (p < 0.05) were found for any of the drugs and 
mean humidity, but significant differences were observed for diclofenac concentration and mean solar 
radiation. Similarly to mean temperature, those positive samples for diclofenac that were collected in 
rural areas were collected on days with low mean solar radiation. As demonstrated by Bartels et al. [66], 
diclofenac is sensitive to solar radiation, and its concentration decreased with solar radiation.  
Based on these findings, diclofenac could have been liberated into the Galician environment, and its 
frequency of detection in this study could have been higher but solar radiation helped to decrease its 
concentration to undetectable levels with the method employed. 
This study has demonstrated that even if Galicia is an area of Spain with high rainfall and low 
population density compared with other areas of Spain, the presence of active compounds such as 
pharmaceuticals in the aquatic environment is common, and these results were similar to results 
published for other areas of Spain such as Catalonia, the Spanish Mediterranean area, Valencia, Madrid 
and Sevilla [27,29,30,32,33,67]. Although drug concentrations were below 200 ng·L−1 (Table 6),  
toxic effects of these compounds in non-target organisms have previously been reported.  
Potential toxicity affected plants and soil organisms due to sulfamethoxazole [8,68] and freshwater 
crustaceans and fish as a result of their exposure to propanolol and diclofenac [9,69]. Based on these 
findings reported by other authors and results obtained for samples collected at sites located next to the 
collection point of a drinking water treatment plant, more than 5% of the samples collected at this site 
were positive for the analysed active compounds, causing significant concern. 
  




The occurrence of drugs in the aquatic environment has recently become a matter of concern.  
This work presents a suitable HPLC-ESI-MS/MS method for the simultaneous extraction,  
detection and quantification of residues of 13 active substances (antimicrobials, glucocorticosteroids,  
non steroidal anti-inflammatories, anti-hypertensives, anti-cancer drugs and triphenylmethane dyes) in 
fresh water. In-house validation according to EPA guidelines makes this method suitable for 
government or private laboratories dedicated to investigating the presence of drugs in the aquatic 
environment. The method was also employed to conduct a monitoring study for the presence of the 
selected analytes in the Galician region with 549 water samples. All the analytes were detected and in 
a range of concentrations between 2.8 and 171.4 ng·L−1. Even if the number of sampling sites located 
in rural areas (with and without farming activity) was more than double the number of sampling sites 
located in urban areas, more positive samples were obtained in samples collected from sites located in 
urban areas, in particular, sites located after the discharge of a WWTP. Rural areas with farming 
activities also had positive samples but always at a percentage below 15% of the samples collected.  
The relationship between concentrations and environmental conditions, physicochemical parameters, 
dates and sampling points were statistically tested, and significant differences were observed only for 
diclofenac and temperature and solar radiation and between propanolol and precipitation. Based on 
these results, active compounds are also present in the Galician environment and even if farming 
activities are conducted in an area, the WWTPs act as a concentration point. 
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